PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23571270-1 2013 Tyrosine phosphorylation (Tyr-P) of focal adhesion kinase (FAK) regulates FAK activation. Tyrosine 0-8 PTK2 protein tyrosine kinase 2 Mus musculus 36-57 23571270-1 2013 Tyrosine phosphorylation (Tyr-P) of focal adhesion kinase (FAK) regulates FAK activation. Tyrosine 0-8 PTK2 protein tyrosine kinase 2 Mus musculus 59-62 23571270-1 2013 Tyrosine phosphorylation (Tyr-P) of focal adhesion kinase (FAK) regulates FAK activation. Tyrosine 0-8 PTK2 protein tyrosine kinase 2 Mus musculus 74-77 23571270-2 2013 Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. Tyrosine 19-22 PTK2 protein tyrosine kinase 2 Mus musculus 15-18 23571270-2 2013 Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. Tyrosine 19-22 PTK2 protein tyrosine kinase 2 Mus musculus 96-99 23571270-2 2013 Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. Tyrosine 19-22 PTK2 protein tyrosine kinase 2 Mus musculus 96-99 23571270-2 2013 Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. Tyrosine 100-103 PTK2 protein tyrosine kinase 2 Mus musculus 15-18 23571270-2 2013 Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. Tyrosine 100-103 PTK2 protein tyrosine kinase 2 Mus musculus 96-99 23571270-2 2013 Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. Tyrosine 100-103 PTK2 protein tyrosine kinase 2 Mus musculus 96-99 23571270-5 2013 Immunoblotting analyses using antibodies against FAK phospho-Tyr 397 and phospho-Tyr 576/577 demonstrated that the time-course of CB1-stimulated FAK 576/577 Tyr-P occurred in three phases: Phase I (0-2 min) maximal Tyr-P, Phase II (5-20 min) rapid decline in Tyr-P, and Phase III (>20 min) plateau in Tyr-P at submaximal levels. Tyrosine 61-64 PTK2 protein tyrosine kinase 2 Mus musculus 49-52 23571270-5 2013 Immunoblotting analyses using antibodies against FAK phospho-Tyr 397 and phospho-Tyr 576/577 demonstrated that the time-course of CB1-stimulated FAK 576/577 Tyr-P occurred in three phases: Phase I (0-2 min) maximal Tyr-P, Phase II (5-20 min) rapid decline in Tyr-P, and Phase III (>20 min) plateau in Tyr-P at submaximal levels. Tyrosine 81-84 PTK2 protein tyrosine kinase 2 Mus musculus 145-148 23571270-7 2013 FAK 397 Tyr-P and Phase I FAK 576/577 Tyr-P involved protein tyrosine phosphatase (PTP1B and Shp1/Shp2)-mediated Src activation, Protein Kinase A (PKA) inhibition, and integrin activation. Tyrosine 8-11 PTK2 protein tyrosine kinase 2 Mus musculus 0-3 23571270-7 2013 FAK 397 Tyr-P and Phase I FAK 576/577 Tyr-P involved protein tyrosine phosphatase (PTP1B and Shp1/Shp2)-mediated Src activation, Protein Kinase A (PKA) inhibition, and integrin activation. Tyrosine 38-41 PTK2 protein tyrosine kinase 2 Mus musculus 26-29